Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Tuberculosis
•
Pulmonology
•
Pulmonary Infections
How do you approach a positive IGRA in a patient with idiopathic NSIP needing a prolonged course of corticosteroid therapy and a prior history MAC in a single sputum culture?
Related Questions
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
What is your approach to prescribing RIPE for 6 month vs rifapentine/moxifloxacin for 4 months in the treatment of drug sensitive TB in the US?
What is the interpretation of two IGRAs with negative mitogen wells, in the absence of immunosuppression?
How would you approach treatment of latent TB for patients who cannot tolerate rifamycins or isoniazid due to allergy, intolerance, or drug-drug interactions?
What is your preferred agent for fungal prophylaxis in a patient post lung transplant with abnormal LFTs?
Have you incorporated the use of MycoTOX profiles into your clinical practice and, if so, in what capacity?
Do add a macrolide for immunomodulatory effect in patients with macrolide-resistant M. abscessus?
Are there situations where you would consider treating E faecalis or E faecium that grows from a respiratory culture?
Should the RSV vaccine be administered to pregnant mothers even if it is not seasonally circulating but they are 32-36 weeks pregnant?
In light of recent measles outbreaks in the US, would you recommend an MMR booster for an immunocompetent patients born before 1957?
